Efficacy and safety of catheter electrical ablation for ventricular tachycardia--experimental and clinical studies.
We studied the factors determining the extent of myocardial damage induced by catheter electrical ablation in 23 mongrel dogs and evaluated the efficacy and safety of catheter electrical ablation in 6 patients with medically refractory ventricular tachycardias (VT). Electrical shocks were delivered on the epicardium (EPI) and endocardium (END) of the ventricular wall of open-chest anesthetized dogs through a 6F USCI electrode catheter. Effect of the extent of electrode contact pressure was examined by the presence or absence of monophasic action potential using the contact electrode technique. The former was defined as the hard touch condition and the latter was defined as the soft touch condition. The myocardial lesion induced by EPI fulguration was larger than that by END fulguration (EPI-100 J soft touch: 10.2 +/- 2.9 mm in diameter, 6.6 +/- 1.6 mm in depth vs END-100 J soft touch: 7.7 +/- 1.7 mm in diameter, 5.0 +/- 1.2 mm in depth; p less than 0.05, p less than 0.05). The lesion diameter and lesion depth were enlarged by increasing the amount of delivered energy. The lesion depth by the hard touch condition was significantly greater than by the soft touch condition. The transmural perforation was observed in all EPI fulguration in the hard touch condition of the right ventricular wall. In the clinical study, one to three shocks (mean 1.8 +/- 0.7) of 60 to 200 J (mean 151 +/- 48 J) were delivered per session in 6 patients with medically refractory VT.(ABSTRACT TRUNCATED AT 250 WORDS)
Nakagawa
H
H
First Department of Internal Medicine, Hiroshima University School of Medicine, Japan.
Okamoto
M
M
Nagata
K
K
Mukai
J
J
Hondo
T
T
Kawagoe
T
T
Morichika
N
N
Tsuchioka
Y
Y
Matsuura
H
H
Takanashi
A
A
D000328:Adult; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000601:surgery; D002311:Cardiomyopathy, Dilated / Q000601:surgery; D004285:Dogs; D004562:Electrocardiography; D004564:Electrocoagulation / Q000009:adverse effects / Q000592:standards*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000601:surgery; D009206:Myocardium / Q000473:pathology; D009336:Necrosis; D011379:Prognosis; D013610:Tachycardia / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*